Multi-Omics Analyses of the Heterogenous Immune Microenvironment in Triple-Negative Breast Cancer Implicate UQCRFS1 Potentiates Tumor Progression.

Scientists offered innovative perspectives on comprehending the heterogeneity within the TME of TNBC, thereby facilitating the elucidation of TNBC biology and providing clinical recommendations for TNBC patients’ prognosis, such as IL32^high Treg infiltration, Malignant Cell Index evaluation, and UQCRFS1 expression.